Role of the small intestinal decompression tube and Gastrografin in the treatment of early postoperative inflammatory small bowel obstruction.
- Author:
Wei LI
1
;
Zhixia LI
;
Dali AN
;
Jing LIU
;
Xiaohu ZHANG
Author Information
- Publication Type:Journal Article
- MeSH: Decompression; Diatrizoate Meglumine; therapeutic use; Humans; Intestinal Obstruction; drug therapy; Intestine, Small; Intubation, Gastrointestinal; Postoperative Complications; Postoperative Period; Prospective Studies; Reoperation
- From: Chinese Journal of Gastrointestinal Surgery 2014;17(3):275-278
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo evaluate the role of the small intestinal decompression tube (SIDT) and Gastrografin in the treatment of early postoperative inflammatory small bowel obstruction (EPISBO).
METHODSTwelve patients presented EPISBO after abdominal surgery in our department from April 2011 to July 2012. Initially, nasogastric tube decompression and other conventional conservative treatment were administrated. After 14 days, obstruction symptom improvement was not obvious, then the SIDT was used. At the same time, Gastrografin was injected into the small bowel through the SIDT in order to demonstrate the site of obstruction of small bowel and its efficacy.
RESULTSIn 11 patients after this management, obstruction symptoms disappeared, bowel function recovered within 3 weeks, and oral feeding occurred gradually. Another patient did not pass flatus after 4 weeks and was reoperated. After postoperative follow-up of 6 months, no case relapsed with intestinal obstruction.
CONCLUSIONFor severe and long course of early postoperative inflammatory intestinal obstruction, intestinal decompression tube plus Gastrografin is safe and effective, and can avoid unnecessary reoperation.
